Company / Cash per Share
BIOMERICA INC Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.14
FY2025
5-year range
$0.25 / $1.14
FY2021-FY2025
Trend
+360.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +360% YoY in FY2025, a notable deviation from the 9-year average annual change of +143%.
Based on SEC 10-K filings.
1.14 in FY2025 with a 5-year CAGR of +5.0%.
Improved from $0.76 to $1.14 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +33.4%
- 5-Year CAGR
- +5.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share increased 360.1% year-over-year.
- Lowest cash per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.14 | +360.1% |
| FY2024 | $0.25 | -67.2% |
| FY2023 | $0.76 | +57.1% |
| FY2022 | $0.48 | +34.4% |
| FY2021 | $0.36 | -59.9% |
| FY2020 | $0.89 | +1055.6% |
| FY2019 | $0.08 | -45.4% |
| FY2018 | $0.14 | -5.6% |
| FY2017 | $0.15 | -39.9% |
| FY2016 | $0.25 | +73.0% |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026